The Role of AI and Biomarkers in Enhancing Parkinson’s Disease Detection and Management
The global parkinson’s disease market is expanding steadily as the prevalence of Parkinson’s disease (PD)—a progressive neurodegenerative disorder—continues to rise worldwide. Characterized by motor symptoms such as tremors, rigidity, and slowed movement, along with non-motor challenges like cognitive decline and sleep disturbances, PD presents a significant...